AMSTERDAM, Jan 29 (Reuters) - The European Medicines
Agency's executive director, Emer Cooke, said on Friday that the
complex package of data provided by AstraZeneca on its
COVID-19 vaccine had made an assessment challenging.
The vice chair of EMA's human medicines committee, Bruno
Sepodes, told a news briefing that the shot should provide
protection for people over the age of 55, based on
immunogenicity results.
They were speaking after the EMA approved the shot for use
in Europe.
(Reporting by Ludwig Burger, Writing by Douglas Busvine;
Editing by Kevin Liffey)
Astrazeneca (AZN)
